| Old Articles: <Older 7701-7710 Newer> |
|---|
 |
Chemistry World
July 25, 2011
Simon Hadlington |
Glucose Meter Adapted to Detect a Range of Targets A common test used worldwide by millions of people with diabetes could be adapted to detect and measure almost any target molecule including drugs, environmental toxins and disease markers.   |
The Motley Fool
July 25, 2011
Jason Moser |
Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker. |
The Motley Fool
July 25, 2011
Brian Orelli |
Bristol-Myers' Acquisition Could Pay for Itself It will gain access to potential milestones. |
The Motley Fool
July 25, 2011
Jordan DiPietro |
Should You Retire With St. Jude? I can't decide for you whether or not this is the best stock for retirement, but it has passed all four tests, which is pretty impressive. |
The Motley Fool
July 25, 2011
Seth Jayson |
Why the Future Looks Bright for Auxilium Pharmaceuticals Although Auxilium Pharmaceuticals shows inventory growth that outpaces revenue growth, the company may also display positive inventory divergence, suggesting management sees increased demand. |
The Motley Fool
July 25, 2011
Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. |
The Motley Fool
July 25, 2011
Brian Stoffel |
My Money Is On This Hot Medical Stock Intuitive Surgical is blazing new paths for surgical procedures. |
The Motley Fool
July 23, 2011 |
Affymetrix Earnings Preview Affymetrix will unveil its latest earnings on Wednesday, July 27. |
The Motley Fool
July 23, 2011 |
Regeneron Pharmaceuticals Earnings Preview Regeneron Pharmaceuticals will unveil its latest earnings on Wednesday, July 27. |
The Motley Fool
July 22, 2011 |
Covance Earnings Preview Drug development company Covance beat estimates by $0.02 last quarter, and investors are hoping it can beat them again. |
| <Older 7701-7710 Newer> Return to current articles. |
